Accumulating data suggest a link between alterations/deficiencies in cytoskeletal proteins and the progression of cardiomyopathy and heart failure, although the molecular basis for this link remains unclear. Cypher/ZASP is a cytoskeletal protein localized in the sarcomeric Z-line.
INTRODUCTION
Dilated cardiomyopathy (DCM), which is characterized primarily by left ventricular dilation and systolic dysfunction, is a leading cause of congestive heart failure in young patients. The recognition that genetic defects may play pivotal roles in the pathogenesis of dilated cardiomyopathy, especially familial DCM, has received increasing attention during the past decade. Mutations in multiple cytoskeletal and sarcomeric genes, such as dystrophin (1), vinculin (2) , desmin (3), titin (4), actin (5), beta myosin heavy chain (6) , and troponin T (7), have been linked to the pathogenesis of familial DCM in both human and mouse models. The anatomical and pathophysiologic phenotypes of these cytoskeletal and sarcomeric gene mutations are associated variably with impaired structural maintenance, deficiencies in intracellular force generation and intercellular force transmission, and alterations in stretch signaling (8) (9) (10) (11) (12) (13) (14) (15) .
However, the molecular mechanisms, linking the gene mutations to a specific DCM phenotype, remain largely unknown.
Cypher is a cytoskeletal protein, which binds to α-actinin in the Z-line of both skeletal and cardiac muscle (16, 17) . Mutations in Z-line alternatively spliced PDZ-motif protein (ZASP), a human orthologue of Cypher, have been identified in patients with isolated noncompaction of the left ventricular myocardium (INLVM), DCM, hypertrophic cardiomyopathy (HCM), as well as skeletal myopathy (18) (19) (20) (21) (22) (23) .
Our previous studies of mice with global ablation of Cypher in all cells revealed a pivotal role of Cypher in striated muscle structure and function. These mutant mice developed a severe form of congenital myopathy and died from functional failure in multiple striated muscles within 1 week at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from 3 after birth (17) . The perinatal lethality of Cypher knockout mice prevented us from further exploring the specific requirement for Cypher in adult myocardium. To overcome this problem and better understand the molecular mechanisms by which mutations in Cypher cause cardiomyopathy, we utilized a conditional approach to knockout Cypher specifically in the heart by crossing floxed Cypher mice with the Mlc2v-Cre mouse line (24) and the myosin heavy chain α-MHC mER-Cre-mER tamoxifen inducible Cre mouse line (25) .
In the present study we report that cardiac-specific Cypher knockout (CKO) mice display disrupted cardiomyocyte ultrastructure and decreased cardiac function, which eventually leads to a severe form of dilated cardiomyopathy with premature death. A similar phenotype is observed in inducible cardiac-specific Cypher knockout mice (ICKO) in which Cypher is specifically ablated in adult myocardium, confirming our results showing an essential role of Cypher in adult myocardium. In both cardiac-specific Cypher knockout models, cardiac dysfunction is accompanied by augmentation of ERK and Stat3 signaling pathways. Furthermore, we demonstrate specific interaction of Cypher's PDZ domain with the C-terminal region of both calsarcin-1 and myotilin.
Taken together, our studies suggest that (i) Cypher plays a pivotal role in maintaining adult cardiac structure and cardiac function, through protein-protein interactions with other Z-line proteins, (ii) myocardial ablation of Cypher results in DCM with premature death, and (iii) specific signaling pathways participate in Cypher mutant mediated dysfunction of the heart and may in concert facilitate the progression to heart failure. 
RESULTS

Generation of Cardiac-Specific Cypher Knockout (CKO) Mice
To specifically knockout Cypher in the heart, a targeting construct was generated containing loxP sites (triangles) flanking exon 1 of the Cypher gene, which is conserved in all six Cypher isoforms ( Fig. 1A) (30) . The neomycin (Neo) selection cassette was flanked by FRT sites, allowing for subsequent excision with FLPase. Targeted ES cells were identified by Southern blot analysis, and gave the expected 6.9kb mutant fragment compared to the 6.2kb wild type fragment (Fig. 1B) . Cypher f/f mice were crossed with Mlc2v-Cre mice to generate cardiacspecific Cypher knockout mice (CKO) in which Cypher is specifically deleted in ventricular cardiomyocytes. Assessment of Cypher protein expression in CKO hearts, using a cardiacspecific Cypher antibody, demonstrated the specific loss of Cypher in CKO hearts from onemonth-old mice as shown in Fig. 1C .
To further investigate the specificity and efficiency of Mlc2v-Cre mediated excision during cardiac development, total protein was extracted from atria and ventricles separately and the Cypher protein level was measured (data not shown). Consistent with previously published data reporting Mlc2v expression only in ventricles (24) , decreased expression of Cypher protein was observed only in ventricles, but not in atria of CKO mouse hearts.
CKO Mice Develop Dilated Cardiomyopathy and Die within 5 Months
Cardiac-specific deletion of Cypher does not affect the Mendelian frequency of viable CKO male and female mice produced at birth. CKO mutants began to die at 16 weeks of age and all died before 23 weeks of age ( Fig. 2A) (Fig. 2B ). Both ratios of heart weight to body weight and heart weight to tibia bone length were significantly increased from 4.65 (mg/g) in control to 6.01 (mg/g) in CKO mice and 6.72
(mg/mm) in control to 9.3 (mg/mm) in CKO mice, respectively ( Fig. 2C & D) .
We next evaluated heart performance by echocardiography on CKO and control mice from 1 to 4 months of age. Whereas no significant differences were found between 1-month-old CKO and control littermate mice, 2 to 4 months old CKO mice showed enlarged left ventricular chamber size as evidenced by a significant increase in left ventricular internal dimension values at end diastole (LVIDd) and end systole (LVIDs) (Fig. 3A , B & C) in agreement with the histological observations (above). In addition, significant wall thinning was seen in CKO hearts as indicated by a significant decrease in interventricular septal wall thickness (IVSd) at end-diastole compared to controls (Table 1 ). More importantly, the changes in cardiac dimensions in CKO mice were accompanied by a dramatic decrease in LV systolic function, showed by a significant decrease in fraction shortening (%FS) and the velocity of circumferential fiber shortening (VCF) as compared to littermate controls (Fig. 3D , Table 1 ). Despite wall thinning, the significant increase in heart size led in CKO mice to an increase in calculated left ventricular mass (LVMd)
as well as left ventricular mass normalized to body weight (LV/BW) at 4 months of age (Table1). ECG analyses also revealed AV block in CKO mice, which was further confirmed by conscious telemetric monitoring of electrocardiograms (data not shown). 
Inducible CKO Mice Exhibit Similar Dilated Cardiomyopathy
In CKO mouse heart, Cypher protein was knocked out by Cre recombinase, mediated by the endogenous Mlc2v promoter, which drives Cre expression from embryonic day 8.75 (24) . To determine whether adult cardiac dysfunction in CKO mice was due to the effect of decreased Cypher in the developing myocardium, we further generated an inducible cardiac-specific ICKO mice began to die from 1 week after tamoxifen injection and all died before 16 weeks after injection. In contrast, 100% were alive in both control groups at least to the time indicated (Fig. 4B) . Dilated cardiomyopathy could be readily determined by the manifestation of a huge heart and severe dilated chambers of both left and right ventricles in ICKO mouse heart ( 
Cypher Interacts with Calsarcin and Myotilin
To understand the molecular basis for the disrupted Z-line structure in CKO mouse hearts, we next studied the effect of Cypher ablation on the protein level and localization of α-actinin, To test the effect of Cypher deficiency on the expression and localization of calsarcin and myotilin, Western blot analyses (Fig. 6D ) and immunostainings (data not shown) were performed on hearts from conventional Cypher knockout mice and control littermates at embryonic day E17.5. This revealed no differences in the expression or localization of either calsarcin or myotilin.
Altered Signals in the Hearts of Cypher Mutant Mice
To examine cardiac hypertrophic biomarkers, dot blot analysis was performed using mRNA isolated from hearts of CKO mice and control littermates at different ages (1, 2, 3, and 4 months of age). As expected, levels of atrial natriuretic factor (ANF), β-myosin heavy chain (MHC) to α-MHC ratio, and skeletal muscle actin were increased at all four ages (Fig. 7A) .
DISCUSSION
Cypher/ZASP is a striated muscle specific protein localized in the sarcomeric Z-line (16, 36) . Our previous studies have demonstrated that conventional ablation of Cypher results in neonatal lethality of mice within 1 week after birth, caused by multiple striated muscle failure with symptoms that include decreased milk intake, limb muscle weakness, and cyanosis (17) . To further investigate the functional role of Cypher in the heart, we generated a conditional cardiacspecific Cypher knockout model using the Cre-loxP system. Homozygous CKO/Cre mice developed a severe form of dilated cardiomyopathy with disrupted cardiac ultrastructure, increased heart weight-to-body weight and heart weight-to-tibia bone length ratios, and Previous studies have demonstrated that Cypher is localized at the Z-line where it binds to α-actinin through its PDZ domain. In the current study we find that Cypher's PDZ domain also interacts with other two Z-line associated proteins, myotilin and calsarcin. However, although ablation of Cypher results in severe DCM, it has no effect on the expression or localization of myotilin, calsarcin, and α-actinin. It should be pointed out that α-actinin is the major component of the Z-line that crosslinks and interacts with many other Z-line proteins, including myotinin and calsarcin, which also bind to each other (34, 41) . This suggests that α-actinin, Cypher, myotilin, and calsarcin are components of a Z-line macromolecular complex, which is essential for the maintenance of Z-line structure during constant muscle contraction. Interestingly, ablation of myotilin and calsarcin also has no effect on the expression or localization of other Zline proteins (42, 43) , suggesting that the Z-line macromolecular complex is different from the Dystrophin-Dystroglycan complex in which ablation of one component down-regulates protein levels of many other components of the complex (44) . Nevertheless, we speculate that although ablation of Cypher, calsarcin, or myotilin has no effect on protein levels of other components of the Z-line complex, it may weaken the protein connections within the complex, thereby disrupting the protein structure and lead to consequent cardiac dysfunction, maladaptive remodeling, signaling changes, and heart failure. From the data presented here, intracellular signaling pathways associated with cardiac protection appear to be increased in the cardiac Cypher ablated mouse heart, suggesting that these pathways may play a common role in mediating cardiac compensation and subsequently the progression to heart failure. Furthermore, the signal transduction pathways that participate in the pathogenesis of cardiac dysfunction may provide potential targets for therapeutic interventions.
In summary, cardiac-specific knockout of Cypher in mouse leads to severe cardiac dysfunction, including DCM and premature lethality from heart failure, with disrupted cellular architecture and altered activities of multiple cellular signaling pathways. Together, the cardiac dysfunction caused by Cypher deficiency likely reflects the integrated effects of impairment of sarcomeric structure and alterations in intracellular signaling cascades. 
MATERIALS AND METHODS
Generation of Gene Targeted Mice
Floxed Cypher mice were generated by standard techniques using a targeting vector containing a neomycin selection cassette flanked by FRT sites (26) . Briefly, exon 1 of Cypher was inserted into 2 flanking LoxP sites (Fig. 1A) . 
DNA Analysis
Genomic DNA was extracted from G418-resistant ES cell clones and mouse tails, as previously described (26) . ES cell DNA was digested by BamHI, electrophorised on a 1% (wt/vol) agarose gel, and subsequently blotted onto a nitrocellulose membrane. A 400-bp fragment was generated by polymerase chain reaction (PCR) using mouse genomic DNA and specific Cypher primers (forward, GAAGGCCCTGAAGAAAGGAGAG ; reverse, GACCCTCCTGTTTCTCCAGGTC).
The PCR product was subsequently radiolabeled using α-[32P]dATP by random priming (Invitrogen). DNA blots were hybridized with the radiolabeled probe and visualized by autoradiography. Mice were genotyped by PCR analysis using mouse tail DNA, Cypher primers (forward, ATCAGTGTCGATGGCATTCA; reverse, TGCAGGCAAACAGTACGAAG) and
Cre primers (forward, GTTCGCAAGAACCTGATGGACA; reverse, CTAGAGCCTGTTTTGCACGTTC) were used to detect floxed Cypher and Cre respectively.
Plasmid Construction for Yeast Two-hybrid Analysis
For yeast two-hybrid analysis, full-length cypher1C (Genbank: AF114378) and full-length cypher2C (Genbank: AY206011) were amplified from a mouse heart cDNA library by PCR using the primers: P1 (5'-cggcgaattcATGTCTTACAGTGTGACTCTGAC-3') and P2 (5'-ctcagtcgacgaGCTCTTAGCTTTTAACATTAAGG-3') and cloned into yeast-two hybrid vector pGBKT7. Full-length calsarcin-1 (Genbank: BC005195) was amplified from a positive clone obtained from a yeast two-hybrid screen using the primers: P3 (5'-aggccgaattcATGCTATCACATAATACTATGATGAAGC-3') and P4 (5'-aatgtcgacgagctcGCACATACAACTTTCTTTTCATAGG-3'), and full-length mouse myotilin (Genbank: BC016214) was amplified from ATCC clone MCG-28747 using primers P5 (5'-ccaagaattcATGTTTAACTACGAACGTCC-3') and P6 (5'-gtaaaggatccAAGTTCTTCACTTTCATAGAG-3'). All fragments were cloned into the yeast-two hybrid vectors pGADT7 and/or pGADT7. Truncated constructs of calsarcin-1 and myotilin were generated by PCR from full-length constructs and cloned into pGADT7.
For coimmunoprecipitations, full-length calsarcin and myotilin were cloned into the mammalian expression vector pXJ40-HA, while full-length and truncated Cypher2C was inserted into the pXJ40-Flag vector (both kindly provided by Dr. Tong Zhang). All constructs were checked by sequencing.
Yeast Two-hybrid Studies
Full-length human cypher2C cDNA, fused to the GAL4 DNA-binding domain (pGBKT7-2C), was used as a bait in a yeast two-hybrid screen of approximately 4 x 10 6 clones from a pretransformed human heart cDNA library (Matchmaker 638833, Clontech) according to the instructions provided by the manufacturer. Briefly, positive clones growing on selective plates, lacking histidine, leucine, adenine and tryptophan, were picked and screened for α-galactosidase activity by plating onto selective plates containing X-α-galactosidase. Plasmid DNA from α-galactosidase positive clones were isolated as described by the manufacturer and sequenced. To confirm interactions, obtained clones were retransformed into yeast with cypher2C or empty pGBKT7 vector. In addition, inserts of pGBKT7 and pGADT7 were swapped and cotransformed calsarcin-1 and myotilin were cotransformed into yeast and positive clones were analyzed for α-galactosidase activity in liquid culture using PNP-α-gal as a substrate (described in the yeast protocols handbook, PT3024-1, Clontech).
Western Blot Analysis
To assess protein expression of cardiac isoforms of Cypher, Western blots analyses were performed on heart lysates from CKO or ICKO mice and control mice using affinity purified
Cypher antibodies as described previously (17) . In subset experiments, antibodies against calsarcin-1 (Alpha diagnostic international), myotilin (kindly provided by Olli Carpen), α-actinin (Sigma), Flag(Sigma), HA(Santa Cruz), phospho-p44/42 MAPK (Thr202/Tyr204), phospho-p38, and phospho-stat3(Cell signaling technology) were used as described (17, 27) . GAPDH antibody was used for normalization. 
In vivo
Hematoxylin and Eosin Staining
Hearts were harvested, relaxed in 50 mM KCl in PBS, fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned into 7-µm thick sections. Hematoxylin and eosin (H & E) staining was performed according to standard procedures.
Transmission Electron Microscopy (TEM)
Hearts were perfused with 50 mM KCL in tyrode solution followed by 2% PFA and 2% glutaraldehyde in 0.15 M Na cacodylate buffer. The tissues were processed for transmission electron microscopy as described previously (17) .
RNA Dot Blot
Total RNA was isolated from ventricles using Trizol reagent (Invitrogen) following the manufacturer's protocol. RNA dot blot was performed as described (28) . Briefly, 2 mg denatured RNA of each sample was blotted on a nitrocellulose membrane and cross-linked by UV. The membrane was then probed with α-[32P]dATP labeled probes and signals were visualized by autoradiography. GAPDH mRNA levels were detected as RNA loading control.
Echocardiography Analysis
Mice were anesthetized with isoflurane and subjected to echocardiography as previously described (29) .
Electrocardiography (ECG) Analysis
Surface electrocardiogram recordings were performed on mice anesthetized with 1%-1.5%
isoflurane. Needle electrodes were used and placed in the conventional lead II position. A differential amplifier (DP-304, Warner Instruments Corp., Hamden, CT) amplified the signals in the bandwidth 0.1-1000Hz, and signals were filtered using an adaptive 60Hz filter (Humbug, Quest Scientific, Vancouver, Canada). The signals were digitized at 3000Hz, and analyzed using ECG Analysis Software (QRS phenotyping, Calgary, Canada).
Statistical Analysis
Statistical analyses were done using Student's unpaired t-Test. P<0.05 was considered statistically significant. Data are represented as means ± standard errors of the means (SEM). 
